Literature DB >> 3109363

Accumulation of chlorpromazine and thiouracil by human melanoma cells in culture.

P G Parsons, B J Allen.   

Abstract

The uptake (total radioactivity in intact cells) and incorporation (radioactivity bound to acid-precipitable material) of 14C-chlorpromazine (CPZ) and 14C-thiouracil (TU) were studied using a library of 3 human fibroblast strains and 13 tumour cell lines. In contrast to previous studies using rodent melanomas in vivo, the melanoma lines, including lines with high tyrosinase and melanin contents, did not take up more CPZ and TU than non-melanoma cells (fibroblasts, HeLa cells). Incorporation of CPZ was also broadly similar in all cell types studied. TU was selectively incorporated into the melanoma line having a high tyrosinase and melanin content but not into lines with high tyrosinase activity and low melanin content. While supporting the possibility of selective therapy for heavily-pigmented melanomas using labelled TU derivatives, these results suggest that the action of potentially melanoma-affined compounds should be further evaluated in human cells. Unlabelled CPZ or TU was not selectively toxic to melanoma cells. Unexpectedly, methylation-sensitive tumour cells (Mer-phenotype) were highly resistant to TU, thus providing a new experimental tool for understanding the genesis of this phenotype in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3109363     DOI: 10.1038/icb.1986.56

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  2 in total

1.  Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines.

Authors:  Michał Otręba; Monika Pajor; Jared D Warncke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-06       Impact factor: 3.000

Review 2.  Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy.

Authors:  Bagher Farhood; Hadi Samadian; Mahdi Ghorbani; Seyed Salman Zakariaee; Courtney Knaup
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.